2021
Predictive value of NT-proBNP in non-obstructive hypertrophic cardiomyopathy
Hutt E, Mentias A, Alashi A, Fava A, Popovic Z, Thamilarasan M, Lever H, Desai M. Predictive value of NT-proBNP in non-obstructive hypertrophic cardiomyopathy. European Heart Journal 2021, 42: ehab724.0765. DOI: 10.1093/eurheartj/ehab724.0765.Peer-Reviewed Original ResearchNT-proBNP ratioLV ejection fractionSerum NT-proBNPNT-proBNPAsymptomatic patientsPrimary endpointSeptal myectomySudden cardiac death risk factorsNon-obstructive hypertrophic cardiomyopathyKaplan-Meier survival analysisDeath risk factorsEarly disease stagesHypertrophic cardiomyopathy patientsImplantable defibrillator dischargesEjection fractionHeart transplantPrimary outcomeRisk stratificationPrognostic valueAdverse outcomesDisease stageCardiomyopathy patientsRisk factorsEcho variablesHypertrophic cardiomyopathy
2018
Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center
Hodges K, Rivas CG, Aguilera J, Borden R, Alashi A, Blackstone EH, Desai MY, Smedira NG. Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center. Journal Of Thoracic And Cardiovascular Surgery 2018, 157: 2289-2299. PMID: 30782406, DOI: 10.1016/j.jtcvs.2018.11.148.Peer-Reviewed Original ResearchConceptsVentricular outflow tract obstructionOutflow tract obstructionMitral valve interventionLeft ventricular outflow tract obstructionTract obstructionSeptal myectomyValve interventionMitral interventionPostoperative ventricular septal defectContemporary surgical outcomesHypertrophic cardiomyopathy centersPapillary muscle resectionMitral valve replacementPermanent pacemaker insertionComplete heart blockMitral valve pathologyVentricular septal defectHospital outcomesOperative mortalityConcomitant proceduresValve replacementMuscle resectionSingle surgeonHeart blockRetrospective review